Free Trial

PTC Therapeutics (PTCT) Earnings Date, Estimates & Call Transcripts

PTC Therapeutics logo
$63.98 -0.93 (-1.43%)
As of 11:05 AM Eastern
This is a fair market value price provided by Massive. Learn more.

PTC Therapeutics Earnings Summary

PTC Therapeutics announced Q3 2026 earnings on October 29, 2026, reporting an EPS of -$0.62, which missed the consensus estimate of $0.14 by $0.76. Quarterly revenue rose 69.6% year-over-year to $357.81 million, above analysts' expectations of $306.43 million. With a trailing EPS of -$1.40, PTC Therapeutics' earnings are expected to grow 467.35% next year, from $0.49 to $2.78 per share.

Latest Q3
Earnings Date
Oct. 29Estimated
Consensus EPS
(Oct. 29)
$0.14
Actual EPS
(Oct. 29)
-$0.62 Missed By -$0.76
Actual Revenue
(Oct. 29)
$357.81M

Q3 2026 Earnings Resources

Get PTC Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PTC Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PTCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PTCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PTC Therapeutics Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20262-$1.03-$0.15-$0.59
Q2 20262-$0.92-$0.28-$0.60
Q3 20262-$0.29-$0.11-$0.20
Q4 20262-$0.23$0.08-$0.08
FY 20268-$2.47-$0.46-$1.47

PTC Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026$0.1434-$0.62 -$0.7634-$0.62$306.43M$357.81M
7/30/2026Q2 2026$0.2363$0.92+$0.6837$0.92$298.63M$360.52M
5/7/2026Q1 2026-$0.45-$0.03+$0.42-$0.03$217.42M$272.55M
2/19/2026Q4 2025-$0.21-$1.67 -$1.46-$1.67$281.45M$164.68M
11/4/2025Q3 2025-$1.19$0.20+$1.39$0.20$177.42M$211.01M
8/7/2025Q2 2025-$1.07-$0.83+$0.24-$0.83$173.01M$178.88M
5/6/2025-$0.85$10.04+$9.19-$437.16M$1.18B

PTC Therapeutics Earnings - Frequently Asked Questions

PTC Therapeutics (NASDAQ:PTCT) last announced its quarterly earning data on Thursday, October 29, 2026. Learn more on PTCT's earnings history.

In the previous quarter, PTC Therapeutics (NASDAQ:PTCT) missed the analysts' consensus estimate of $0.14 by $0.76 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. PTCT's actual earnings.

The conference call for PTC Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for PTC Therapeutics' latest earnings report can be read online.
Read Transcript

PTC Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

PTC Therapeutics (NASDAQ:PTCT) has a recorded annual revenue of $1.73 billion.

PTC Therapeutics (NASDAQ:PTCT) has a recorded net income of $682.64 million. PTCT has generated -$1.40 earnings per share over the last four quarters.

PTC Therapeutics (NASDAQ:PTCT) has a forward price-to-earnings ratio of 23.35. The price/earnings-to-growth ratio is 4.71.

PTC Therapeutics' earnings are expected to grow from $0.49 per share to $2.78 per share in the next year, which is a 467.35% increase.


Earnings data for NASDAQ:PTCT is sourced from Fiscal.ai, with the most recent quarter reported on 10/29/2026. New results are added as companies report their earnings.
From Our Partners